Industry Reports
Sharp completes first phase of $23 million investment in its Bethlehem clinical services facility
Sharp - a part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has completed the first phase in...
News
ANTABIO Announces Key Executive Appointments
Antabio SAS, a biopharmaceutical company developing novel antibacterial treatments in areas of highest unmet needs, is pleased to announce the addition of four highly...
News
Juniper Pharma Services’ co-founder awarded CBE in the Queen’s New Year’s Honours List
Juniper Pharma Services , a subsidiary of Juniper Pharmaceuticals, Inc, is proud to announce that its co-founder Martyn Davies has been appointed as a...
Drug Research
Myriad Genetics Announces Expanded Research Collaboration with AstraZeneca
Myriad Genetics, Inc. , a leader in molecular diagnostics and personalized medicine, announced that AstraZeneca will use the Company’s myChoice® HRD Plus in an...
Drug Research
NexImmune Raises $23 Million to Advance Endogenous Cellular ImmunoTherapy into Clinical Development
NexImmune, an emerging leader in the field of antigen-directed immunotherapy, announced the closing of a Series A financing co-led by new investor ArrowMark Partners...
Clinical Trials
Adverum Biotechnologies Doses First Patient in the ADVANCE Phase 1/2 Clinical Trial of ADVM-043 for A1AT Deficiency
Adverum Biotechnologies, Inc , a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, announced the dosing of the...
Research Insight
Organovo Receives Orphan Designation From U.S. FDA for 3D Bioprinted Therapeutic Liver Tissue Treatment of Alpha-1 Antitrypsin Deficiency
Organovo Holdings, Inc announced that the U.S. FDA granted orphan drug designation for the Company’s treatment of alpha-1 antitrypsin deficiency (“A1AT”) with its 3D...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read